TINA DOCHNIAK: Open Payments
NPI 1427094937 · LOXAHATCHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,950 in 76 payments from 16 companies in 2025. Trend: 2023 $2,605 · 2024 $1,763 · 2025 $1,950
Food & beverage: $1,950
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $452 |
| AstraZeneca Pharmaceuticals LP | 12 | $353 |
| Novo Nordisk Inc | 10 | $266 |
| ABBVIE INC. | 12 | $202 |
| Abbott Laboratories | 2 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $135 |
| Exact Sciences Corporation | 3 | $92 |
| SANOFI-AVENTIS U.S. LLC | 3 | $90 |
| Lilly USA, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $34 |
Products named: NURTEC ODT, AIRSUPRA, Ozempic, XIFAXAN, ESPRIT, TZIELD, ELIQUIS, QULIPTA.
Industry payments across FL — which companies pay providers there.
